High-Content Analysis
The Screening Facility couples genetic and chemical high throughput screening with multiparametric phenotypic image analysis to support translational cancer research. We employ functional genomics (siRNA, shRNA, CRISPR) tools in both pooled and arrayed approaches to support target identification and target validation in multiple types of cancer. Our state-of-the-art image analysis capabilities, including a machine learning module, support identification of a suite of cellular phenotypes in both 2D and 3D environments.
Our Perkin Elmer Opera High-Content Screening system is supported by a robotic plate-loading arm, and JANUS and Wellmate liquid handling systems.
High-Content Analysis Equipment
High-Content Analysis Team
Lynn McGarryHigh Content Screening |
|
Ryan CorbynImage Analysis |
|